Skip to main content

Nonacus ExomeCG Exome Capture Kit

Nonacus of Birmingham, UK, has launched ExomeCG, a "clinically enhanced" exome capture kit that is designed to enable whole-exome sequencing and targeted copy number analysis in a single assay. According to the company's website, the kit provides CNV detection at loci known to have both gene- and exon-level rearrangements, which enables researchers to replace array- and MLPA-based CNV analyses. Codeveloped with bioinformatics firm Congenica, ExomeCG can be used in combination with that company's clinical decision support platform to interpret next-generation sequencing data for clinical decision making, Nonacus said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.